CClinicalTrials.gg
CompletedNCT02125201Updated Feb 6, 2018

Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention

A Phase 4 interventional study of Fentanyl in Pain, sponsored by HaEmek Medical Center, Israel. Completed at 1 site in Israel. Open to participants aged Up to 3 Months. Per ClinicalTrials.gov, last updated 2018-02-06.

Sponsored by HaEmek Medical Center, Israel · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
Up to 3 Months
Sex
All
01

Study summary

Neonatal intensive care unit patients undergoes many painful procedures during their hospitalization. Effective pain control in such procedures as intubation, catheterization, central line insertion, chest tube insertion, etc. is an important part of treatment. Opioids administration is a common practice for acute pain prevention. Fentanyl is the preferred opioid due to it rapid onset and short duration of action.

Fentanyl may be given intravenously, transcutaneous transmucosal and intranasal. Intranasal administration is practiced for about 20 years. A rich vascular supply in a nose provides rapid absorption of the drug. This uninvasive root is now popular for pain prevention and treatment. There are about 20 trials with intranasal fentanyl administration to children from 6 month old to 18 years. The investigators did not find information about this way of administration in neonates.

In our pilot study the investigators want to check if intranasal administration of fentanyl is safe and effective in pain prevention in term and preterm neonates during invasive procedures and to compare it with intravenous route of administration.

02

Conditions studied

  • Pain

Keywords

  • intranasal fentanyl
  • newborn
03

In context

Lead sponsor

HaEmek Medical Center, Israel is the lead sponsor of 228 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 3 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Term and preterm neonates that require invasive procedures (elective or semielective intubation, central line insertion , chest drain or abdominal drain)

Exclusion criteria

Exclusion Criteria:

  1. Neonates with prolonged analgesic treatment before the procedure
  2. Neonates with neurologic problem which can interact with pain assessment
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    intranasal fentanyl

    Intranasal Fentanyl 1.5-2 mcg/kg

    Drug: Fentanyl

  • Active comparator
    intravenous fentanyl

    Intravenous Fentanyl 1-1.5 mcg/kg

    Drug: Fentanyl

Interventions

  • DrugFentanyl

    A neonate will recieve Fentanyl intranasal or intravenous 5 minutes before the procedure The nurse will check his pain scale If the pain scale will be more than 4 the neonate will recieve the second dose of Fentanyl

    Also known as: Beatryl

06

What researchers measure

Primary outcomes

  1. Pain scale - N-PASS

    Time frame: before the intervention and till one our after intervention

07

Study locations

1 site
  • NICU
    Afula, Israel
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02125201
Lead sponsor
HaEmek Medical Center, Israel
Responsible party
Peniakov Marina (Doctor, HaEmek Medical Center, Israel) — Principal investigator
First posted
Apr 29, 2014
Start date
Jun 2014
Primary completion
Mar 2015
Completion
Mar 2015
Last update
Feb 6, 2018

Study contacts

Marina Peniakov, MD
principal investigator · HaEmek Medical Center, Israel

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion